New research shows that dementia risk is best predicted by combining genetic vulnerability with cardiovascular disease ...

A UCSF-led study reveals combining genetic risk factors like APOE4 with cardiovascular risks such as high LDL, obesity, and ...

Image Combining genetic risk with cardiovascular disease risk factors - such as high LDL cholesterol, obesity, and hypertension - may predict who ...

Combining genetic risk with cardiovascular disease risk factors—such as high LDL cholesterol, obesity, and hypertension—may ...

For individuals who are currently cognitively unimpaired, the risk of MCI and dementia increases with increasing amyloid PET centiloid value.

Neurogen Biomarking and Tasso, Inc. today announced a broad partnership agreement in which Neurogen will adopt Tasso's ...

Distinguishing early forms of cognitive impairment from normal aging can be a difficult diagnostic puzzle. Most primary care ...

Alzheimer's disease (AD) is a progressive neurodegenerative disorder characterized by cognitive decline such as memory loss ...

A new meta-analysis of six randomized controlled trials shows that lithium supplementation does not significantly slow cognitive decline in people with mild cognitive impairment or Alzheimer’s disease ...

The annual meeting of the American Heart Association was held this year from Nov. 7 to 10 in New Orleans, drawing attendees ...

New research published in the journal Nature suggests that modest doses of lithium orotate may prevent or even reverse ...

Biogen and Eisai have announced that the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has approved an ...